While biotech may be the next big thing, making money through it isn’t easy. Indeed, investing in biotech stocks is often more of an art than a science. And considering these companies are solely focused on scientific endeavors, that’s not what many investors want to hear. For every Moderna (NASDAQ:MRNA), which shot to wealth and fame on…

The best retirement stocks for investors over 50 have reliability in common. Retirement stocks come in a few flavors, but the best retirement stocks for investors over 50 provide a mix of growth, stability and income. First, you want growth because you’ve probably got more than 30 more years of life expectancy, and you can’t…

Source: Shutterstock ProQR (NASDAQ:PRQR) stock is rising on Thursday thanks to an expanded licensing and collaboration agreement with Eli Lilly (NYSE:LLY). Specifically, the agreement concerns ProQR’s Axiomer RNA-editing platform. The goal of developing this platform is for the treatment of both liver and nervous system disorders. ProQR notes that recent developments with Axiomer have “significantly…

Major indices such as the S&P 500 and the Nasdaq Composite may have plunged by double-digits during 2022, but certain areas of the stock market performed strongly throughout the year. One of those areas is among the hottest healthcare stocks. With company-specific catalysts outweighing negative macro factors such as high inflation, rising interest rates, and slowing economic growth, scores…

The omicron variant of Covid-19 has sent several pharmaceutical companies flying higher this past week, such as Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE). Today, shares of Adagio Therapeutics (NASDAQ:ADGI) are soaring higher by 80% after closing the previous trading session 34% higher. The company only has a market capitalization of $5 billion, but it issued a…

Biotech stocks are infamously one of the most volatile sectors in the stock market. Investors often venture into speculative companies with no proven pipelines. Emerging firms with a pipeline of drugs and products still in the clinical phase post little to no revenue. They raise cash by tapping capital markets to pay for research and…

Stocks continue to chop around all-time highs as investors await more direction amid earnings. That said, let’s look at a few top stock trades starting with some cryptocurrencies. Top Stock Trades for Tomorrow No. 1: Ethereum (ETH-USD) The crypto trade has been on fire lately. Ethereum (CCC:ETH-USD) has rallied in 12 of the past 13…

Atossa Therapeutics (NASDAQ:ATOS) is a highly intriguing company that has a great deal of potential. I recommend, however, that investors avoid taking a bullish position in ATOS stock for now. Source: CI Photos / Shutterstock.com That’s because Atossa is a very high-risk name. A Promising Breast Cancer Treatment Atossa is developing Endoxifen, which the company…

A decade ago, after returning to finance from 30 years covering computer technology, I got into an argument over a company called Dendreon. You’ll see why this lingering thoughts connects me to BIIB stock below. Source: PictureDesignSwiss / Shutterstock.com Dendreon had launched a treatment for prostate cancer called Provenge. It is an immunotherapy, tied to…

A happier title for today’s note is: Three stocks to buy going into the holidays. However I mean to scare readers by sounding more bearish than I really am about these companies. In the long run, these are stocks to buy with confidence but from better vantage. For now they are stocks to avoid. The…

Copyright © 2021 InvestorPlace Media, LLC. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201. Home / Today’s Market / Midday Market Update: 10 Biggest Stocks Gainers Today TTD is leading today’s gainers By William White, InvestorPlace Writer Jun 24, 2021, 12:00 pm EDT June 24, 2021 We’re halfway through trading hours on Thursday…

Luminar Technologies (NASDAQ:LAZR) stock is on the rise Thursday following news that it will become standard in the next electric vehicle (EV) from Volvo. Source: JHVEPhoto/shutterstock.com Volvo is planning to reveal the successor to its XC90 next year. When it does, the EV will feature lidar hardware. This is where Luminar Technologies comes into play.…

890 5th Avenue Partners (NASDAQ:ENFA) stock is getting some chatter today as investors weigh out the recent merger news with BuzzFeed. Source: Dmitry Demidovich/ShutterStock.com 890 5th Avenue Partners, a special purpose acquisition company (SPAC), announced that it will be acting as a vehicle to take Buzzfeed, an online publication and entertainment company, public. Here’s what…

Eli Lilly (NYSE:LLY) stock is soaring higher on Thursday following news of a decision from the U.S. Food and Drug Administration (FDA) for its new Alzheimer’s drug. Source: Jonathan Weiss / Shutterstock.com A recent press release reveals that the FDA has granted Breakthrough Therapy designation for donanemab. This is Eli Lilly’s antibody that targets “a…

Battered bulls fearing for a continuation of last week’s selloff are breathing a sigh of relief this morning. Equity markets are buoyant, and risk appetite is returning. Notably, the sectors that were smacked hardest last week are rallying the most today. Small-caps are leading the charge on the index level, with the Russell 2000 Index…

Friday was a quadruple expiration day in the markets, one of four throughout the year. It marks the expiration of several different assets related to futures and options. As such, it can create a pretty bumpy trading session. Despite that, let’s look at a few top stock trades for next week. Top Stock Trades for…

Biogen (NASDAQ:BIIB) stock ripped higher this week on approval of its Alzheimer’s drug, Aduhelm. Source: PictureDesignSwiss / Shutterstock.com Analysts seemed taken with Biogen’s proposed pricing, $56,000 per year. It’s based on the cost of Alzheimer’s in lost life and nursing care. A scientific panel refused to endorse the drug last year. The panel voted 8-1…